These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10973198)

  • 1. Protein C may be sepsis solution.
    Garber K
    Nat Biotechnol; 2000 Sep; 18(9):917-8. PubMed ID: 10973198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    van Zanten AR; Bakker J; van den Berg PC; Girbes AR; van Leeuwen SJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1179. PubMed ID: 11433670
    [No Abstract]   [Full Text] [Related]  

  • 3. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    Bartelink AK; van Deuren M
    Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1178-9. PubMed ID: 11433669
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammation and coagulation: implications for the septic patient.
    Dellinger RP
    Clin Infect Dis; 2003 May; 36(10):1259-65. PubMed ID: 12746771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activated protein C, coagulation, inflammation, and treatment of severe sepsis].
    van Deventer SJ; Pajkrt D
    Ned Tijdschr Geneeskd; 2001 Mar; 145(13):613-6. PubMed ID: 11305209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activated protein C in sepsis].
    Brandtzaeg P
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):766. PubMed ID: 15039802
    [No Abstract]   [Full Text] [Related]  

  • 7. Drotrecogin alpha and anticoagulants in septic patients after cardiac surgery.
    Pappalardo F; Cristallo E; Franco A; Antonioli G; Zangrillo A
    Eur J Anaesthesiol; 2007 Mar; 24(3):294-5. PubMed ID: 17054810
    [No Abstract]   [Full Text] [Related]  

  • 8. Activated protein C for sepsis.
    Toussaint S; Gerlach H
    N Engl J Med; 2009 Dec; 361(27):2646-52. PubMed ID: 20042756
    [No Abstract]   [Full Text] [Related]  

  • 9. Activated protein C for severe sepsis.
    Ely EW; Bernard GR; Vincent JL
    N Engl J Med; 2002 Sep; 347(13):1035-6. PubMed ID: 12324564
    [No Abstract]   [Full Text] [Related]  

  • 10. Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly.
    Eichacker PQ; Natanson C; Danner RL
    N Engl J Med; 2006 Oct; 355(16):1640-2. PubMed ID: 17050887
    [No Abstract]   [Full Text] [Related]  

  • 11. Drotrecogin alfa: excess mortality in the least severely ill patients.
    Prescrire Int; 2005 Aug; 14(78):145. PubMed ID: 16108104
    [No Abstract]   [Full Text] [Related]  

  • 12. Activated protein C for the treatment of severe sepsis.
    Houston G; Cuthbertson BH
    Clin Microbiol Infect; 2009 Apr; 15(4):319-24. PubMed ID: 19416303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    Ott A
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2196-7. PubMed ID: 11727624
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant activated protein C in pediatric sepsis.
    Dalton HJ
    Pediatr Infect Dis J; 2003 Aug; 22(8):743-5. PubMed ID: 12913779
    [No Abstract]   [Full Text] [Related]  

  • 15. [Exogenous activated protein C in severe sepsis].
    Mamontova OA; Protsenko DN; Eliutin DV; Kirienko PN; Gel'fand BR
    Anesteziol Reanimatol; 2005; (3):42-5. PubMed ID: 16076046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First sepsis drug nears market.
    DeFrancesco L
    Nat Med; 2001 May; 7(5):516-7. PubMed ID: 11329033
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe sepsis and therapy with activated protein C.
    Parrillo JE
    N Engl J Med; 2005 Sep; 353(13):1398-400. PubMed ID: 16192486
    [No Abstract]   [Full Text] [Related]  

  • 18. Risks and benefits of activated protein C treatment for severe sepsis.
    Warren HS; Suffredini AF; Eichacker PQ; Munford RS
    N Engl J Med; 2002 Sep; 347(13):1027-30. PubMed ID: 12324562
    [No Abstract]   [Full Text] [Related]  

  • 19. [Should patients with severe sepsis be treated with activated protein C?].
    Laake JH; Bergmann JB; Riddervold F; Bjørneklett A; Aukrust P; Frøland SS
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):782-4. PubMed ID: 15039808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical trials for severe sepsis/DIC].
    Kushimoto S
    Rinsho Byori; 2011 Feb; Suppl 147():85-94. PubMed ID: 21761754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.